China NMPA Product Recall - Hip system

The National Medical Products Administration (NMPA) reported on April 28, 2020, a voluntary Class II recall initiated by Smith & Nephew Medical Products International Trading (Shanghai) Co., Ltd. The recall involves their Hip Acetabular System. The primary issue stems from manufacturing discrepancies, causing certain product specifications to deviate from design requirements. This defect could lead to significant challenges during surgical procedures, specifically difficulties in intraoperative locking and potential installation failure of the device. The company's decision to recall the product follows the receipt of six global complaints since 2018, all detailing the same mode of failure. While the document does not specify inspection dates, the recall is a direct response to these reported product performance issues. Operating under the NMPA's medical device regulatory framework in China, Smith & Nephew is taking proactive measures to address these quality concerns. The required action involves retrieving the affected products from the market, with specific models, specifications, and batch details outlined in the accompanying Medical Device Recall Event Report Form. This recall underscores the importance of stringent manufacturing quality control in medical device production to ensure patient safety and product efficacy.